Chemours is down -9.1%, or -$2.62 to $26.26.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Chemours Company Q4 and Full Year 2023 Financial Webcast Summary
- Chemours Company Under Pressure: Costly Internal Reviews and System Upgrades Threaten Financial Health
- Chemours (NYSE:CC) Plunges as Internal Review Uncovers Financial Weaknesses
- Chemours falls -13.4%
- Chemours Company Concludes Audit Committee Review